Thyrocare Technologies has informed that a meeting of the Board of Directors of the Company will be held on July 22, 2016, to consider and approve unaudited Standalone financial results of the Company for the quarter ended June 30, 2016. The Company also submitting the unaudited Consolidated financial results of the Company and its subsidiary for the above quarter. Further, pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, the trading window of the Company will remain closed for trading in Company’s equity shares for Directors / Designated Employees from July 18, 2016 to July 25, 2016.
The above information is a part of company’s filings submitted to BSE.
